Almost exactly two years after its debut at the 2020 JP Morgan confab — and on the heels of a new
Dominic Borie, Kyverna Therapeutics CEO January 26, 2022 06:27 AM EST FinancingCell/Gene Tx Well-connected, Gilead-backed biotech gets another stack of cash to pursue CAR-Ts for autoimmune disease Josh Sullivan Almost exactly two years after its debut at the 2020 JP Morgan confab — and on the heels of a new Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
